Angels Investments in High Tech

1 stories about Angels Investments in High Tech
מריוס נכט 2

Marius Nacht Buys Controlling Stake in Universal Flu Vaccine Developer BiondVax

17.07.19|Micky Grunfeld
Based in Jerusalem, Nasdaq-listed BiondVax develops a universal flu vaccine, currently in advanced clinical trials